- Product details
- Data
- FAQ
- Related videos
Product Introduction
Like retroviral vectors, RCL can integrate into the cellular genome, thereby posing a risk of secondary tumors induced by integration, which may activate proto-oncogenes, disrupt tumor suppressor genes, or increase the expression of cell growth-promoting factors. The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) newly issued the "Technical Guidelines for Pharmaceutical Research and Evaluation of In Vivo Gene Therapy Products (Trial)" and "Technical Guidelines for Pharmaceutical Research and Evaluation of In Vitro Gene-Modified Systems (Trial)" in May 2022, both of which mention that RCL detection, as a safety test, is crucial in the research and development as well as production of cell-based drugs.
Independently developed by Junyan Bio, the RCL Gene Copy Number (qPCR) Detection Kit is designed for the viral envelope protein VSV-G gene. It features strong specificity and high sensitivity, enabling rapid and specific quantitative detection of RCL in lentiviral vector-related cellular products. This kit can be used in conjunction with Junyan Bio's "Host Cell Residual DNA (Magnetic Bead Method) Sample Pretreatment Kit" and automatic nucleic acid extractors.
Follow us
Sales: +86 15234188795/18701864343
Tech : +86 19503412257
E-mail: sales@junyanbios.cn
Add: Building D, No. 13 Building, Liandong U Valley Taiyuan Science and Technology Innovation Center, No. 100 Tanghuai Road, Xiaodian District, Taiyuan City, Shanxi Province
Copyright © 2025-2026 All Rights Reserved. :晋ICP备2024052786号-2